Healthline

Side Effects of Welchol: What You Need to Know

Welchol (colesevelam hydrochloride) is a prescription drug that’s used to treat high cholesterol and type 2 diabetes. Welchol can cause side effects that range from mild to serious. Examples include ...
EurekAlert!

WelChol(R), in combination with Lipitor(R), cuts LDL cholesterol levels by 48%

Parsippany, N.J. (December 27, 2001) -- WelChol® (colesevelam HCl) and Lipitor® (atorvastatin calcium), taken in combination, can lower LDL cholesterol levels by 48% in patients with moderately high ...
Monthly Prescribing Reference

Welchol gains pediatric indication

WELCHOL (colesevelam) 1.875gram, 3.75gram single dose packets or 625mg tablets by Daiichi Sankyo The FDA has approved Welchol (colesevelam HCl, from Daiichi-Sankyo) as an adjunct to diet and exercise ...
EurekAlert!

New study demonstrates co-administration

Parsippany, NJ (October 15, 2004) – The results of a new study, published in the September 2004 issue of Clinical Pharmacokinetics, showed that no significant drug-drug interaction occurred when ...
Monthly Prescribing Reference

Welchol For Oral Suspension

Welchol For Oral Suspension Interactions Interactions Monitor drugs with a narrow therapeutic index, cyclosporine, glimepiride, glipizide, olmesartan medoxomil, glyburide, levothyroxine, oral ...
Medindia

New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes

PARSIPPANY, N.J., April 23 /PRNewswire/ -- Results of a new study showed that Welchol® (colesevelam HCl) 3.75 g/d significantly improved lipid and glycemic measures in patients with high LDL ...
Medscape

FDA clears colesevelam for FH in kids

Silver Spring, MD - The US Food and Drug Administration has approved an expanded indication for colesevelam HCl tablets and a new powder for oral suspension (Welchol, Daiichi Sankyo) as an adjunct to ...
Medscape

Colesevelam Effective as Add-On Therapy in Type 2 Diabetes

May 9, 2011 (San Diego, California) — Colesevelam (Welchol, Daiichi-Sankyo Pharmaceuticals) might not be a first choice for many clinicians in the treatment of type 2 diabetes; however, a post hoc ...
FiercePharma

Watson Confirms Welchol® Patent Challenge

PARSIPPANY, N.J., April 20, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application ...
Medindia

Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated

PARSIPPANY, N.J., May 30 Daiichi Sankyo, Inc., announcedtoday that data from post-hoc analyses of three pivotal studies demonstratedthat the addition of Welchol(TM), (colesevelam HCl) to common ...
Drug Store News

WelChol approved by FDA to aid glycemic control in diabetics

WASHINGTON Daiichi Sankyo has received approval from the Food and Drug Administration for its application for WelChol tablets to improve glycemic control. WelChol (colesevelam hydrochloride) is ...
FiercePharma

Watson Confirms Welchol® Oral Suspension Patent Challenge

MORRISTOWN, N.J., Jan. 25, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an ...